Skip to content

Effectiveness of Sagalanoi Chooranam (Polyherbal Powder) in the management of Thookaminmai (Insomnia)

An Open Non Randomized Clinical Trial To Evaluate The Effectiveness Of Sagalanoi Chooranam In The Management Of Thookaminmai (Primary Insomnia) Among Out-Patients Attending Ayothidoss Pandithar Hospital, National Institute Of Siddha

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040108
Enrollment
10
Registered
2022-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

Interventions

Intervention1: Sagalanoi Chooranam: 1340 mg BD with Warm water after food Control Intervention1: NIL: NIL

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients reporting with symptoms of Thookaminmai (Insomnia) 1. difficulty falling asleep, staying asleep, or nonrestorative sleep; 2. this difficulty is present despite adequate opportunity and circumstance to sleep; 3. this impairment in sleep is associated with daytime impairment or distress; and 4. this sleep difficulty for at least 3 times per week and for at least 1 month.

Exclusion criteria

Exclusion criteria: Patients with a Known cases of 1. Uncontrolled Hypertension. 2. Thyroid dysfunction 3. Diabetes 4. Chronic renal failure 5. Neurological disease 6. Obstructive sleep apnoea syndrome 7. Coronary disease 8. Pregnancy and lactation 9. Malignancy 10. Drug addicts 11. Shift Workers & Drivers

Design outcomes

Primary

MeasureTime frame
Primary Outcome will be assessed by comparing scores of Pittsburgh Sleep Quality Index pre and post treatmentTimepoint: 2 Months - Screening 2 Months - Patient Enrollment 2 Months - Outcome Assessment

Secondary

MeasureTime frame
Secondary Outcome will be assessed by comparing scores of Perceived Stress Scale 14 pre and post treatmentTimepoint: 2 Months - Screening 2 Months - Patient Enrollment 2 Months - Outcome Assessment

Countries

India

Contacts

Public ContactDr T Lakshmikantham MDS PhD

National Institute of Siddha

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026